Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S., New Zealand Firms Join To Produce Animals For Biosimilars

This article was originally published in PharmAsia News

Executive Summary

A U.S. company has entered into an agreement with a New Zealand partner to develop animals capable of being used to produce biosimilar drugs. Under the plan, GTC Biotherapeutics of the United States and AgResearch of New Zealand will collaborate in producing biosimilars of existing products. The New Zealand government also is heavily involved in the project and offers its backing to research efforts. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts